Developing therapies for rare diseases requires more than scientific innovation. It demands a robust regulatory strategy supported by high-quality medical and scientific documentation.
Hoy, 30 de junio de 2026, finaliza el plazo de registro de alérgenos del Grupo II (ácaros).
In drug development, high-quality documentation is more than a deliverable — it is a strategic asset that
At Asphalion, we’re excited to be part of key events, conferences, and summits throughout 2026—great opportunities to connect, exchange insights, and collaborate with leaders across healthcare and medical devices.
Preparing an MAA or NDA? Rigorous writing, a clear narrative, and a thorough understanding of regulatory expectations
Our expert, Maria Castellà, participated this week in the ATMP Catalonia Series event, organized by Vall d’Hebron
We are pleased to announce that our expert Maria Castellà will participate in the upcoming ATMP Catalonia
At Asphalion, we are proud to work with outstanding professionals who combine deep scientific expertise with strategic
Search or filter
Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts.
We will be happy to assist you!
